Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Identification of the Most Relevant Risk Factors for Thromboembolism

NCT04246073 is registered in ClinicalTrials.gov with Hellenic Society of Surgical Oncology as lead sponsor.

NCT NCT04246073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04246073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Identification of the Most Relevant Risk Factors for Thromboembolism
Lead sponsor
Hellenic Society of Surgical Oncology
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2019
Completion date
December 1, 2020
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cancer diagnosis, thromboembolism